이스라엘 - 히브리어 - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine

이스라엘 - 히브리어 - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 3 mg - rivastigmine

이스라엘 - 히브리어 - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine

이스라엘 - 히브리어 - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 6 mg - rivastigmine

이스라엘 - 히브리어 - Ministry of Health

mip veterinaria ltd - dexamethasone as dihydrogen phosphate disodium - תמיסה להזרקה - dexamethasone as dihydrogen phosphate disodium 4 mg / 1 ml

이스라엘 - 히브리어 - Ministry of Health

unipharm ltd, israel - clopidogrel as hydrogen sulfate - טבליה - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : patients suffering from myocardial infarction (from a few days until less than 35 days ) ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: for patients with acute coronary syndrome (non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ) in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or cabg . clo

이스라엘 - 히브리어 - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; lactic acid; magnesium chloride hexahydrate; sodium carbonate hydrogen; sodium chloride - תמיסה להמופילטרציה - calcium chloride dihydrate 5.145 g / 1000 ml; magnesium chloride hexahydrate 2.033 g / 1000 ml; lactic acid 5.400 g / 1000 ml; sodium chloride 6.45 g / 1000 ml; sodium carbonate hydrogen 3.090 g / 1000 ml - combinations of electrolytes - combinations of electrolytes - as substitution solution in continuous haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis for acute renal failure.

이스라엘 - 히브리어 - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride dihydrate; glucose as monohydrate; magnesium chloride hexahydrate; sodium carbonate hydrogen; sodium chloride - תמיסה להמודיאליזה\המופילטרציה - sodium chloride 6.136 g/l; calcium chloride dihydrate 0.2205 g/l; sodium carbonate hydrogen 2.940 g/l; glucose as monohydrate 1 g/l; magnesium chloride hexahydrate 0.1017 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with acute renal failure, requiring continuous haemofiltration.

이스라엘 - 히브리어 - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride dihydrate; glucose as monohydrate; magnesium chloride hexahydrate; potassium chloride; sodium carbonate hydrogen; sodium chloride - תמיסה להמודיאליזה\המופילטרציה - calcium chloride dihydrate 0.2205 g/l; glucose as monohydrate 1 g/l; magnesium chloride hexahydrate 0.1017 g/l; potassium chloride 0.2237 g/l; sodium carbonate hydrogen 2.940 g/l; sodium chloride 6.136 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with acute renal failure, requiring continuous haemofiltration.

이스라엘 - 히브리어 - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride dihydrate; glucose as monohydrate; magnesium chloride hexahydrate; potassium chloride; sodium carbonate hydrogen; sodium chloride - תמיסה להמודיאליזה\המופילטרציה - glucose as monohydrate 1 g/l; magnesium chloride hexahydrate 0.1017 g/l; potassium chloride 0.2982 g/l; calcium chloride dihydrate 0.2205 g/l; sodium carbonate hydrogen 2.940 g/l; sodium chloride 6.136 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with acute renal failure, requiring continuous haemofiltration.